Attached files
| file | filename |
|---|---|
| EX-31.1 - CERTIFICATION - Pivot Pharmaceuticals Inc. | neukd_ex311.htm |
| EX-3.13 - CERTIFICATE OF NAME CHANGE - Pivot Pharmaceuticals Inc. | neukd_ex313.htm |
| EX-31.2 - CERTIFICATION - Pivot Pharmaceuticals Inc. | neukd_ex312.htm |
| EXCEL - IDEA: XBRL DOCUMENT - Pivot Pharmaceuticals Inc. | Financial_Report.xls |
| EX-99.1 - AUDIT COMMITTEE CHARTER - Pivot Pharmaceuticals Inc. | neukd_ex991.htm |
| EX-32.2 - CERTIFICATION - Pivot Pharmaceuticals Inc. | neukd_ex322.htm |
| 10-K - FORM 10-K - Pivot Pharmaceuticals Inc. | neukd_10k.htm |
EXHIBIT 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
I, Dr. BJ Bormann, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
|
(1) |
the Annual Report on Form 10-K of Pivot Pharmaceuticals Inc. for the year ended January 31, 2015 (the "Report") fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|
|
|
|
(2) |
the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Pivot Pharmaceuticals Inc. |
| Dated: May 15, 2015 | By: |
/s/ BJ Bormann |
|
|
Dr. BJ Bormann |
|||
|
Chief Executive Officer and Director |
|||
|
(Principal Executive Officer) |
|||
|
Pivot Pharmaceuticals Inc. |
|||
A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to Pivot Pharmaceuticals Inc. and will be retained by Pivot Pharmaceuticals Inc. and furnished to the Securities and Exchange Commission or its staff upon request.